{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T22:31:27Z","timestamp":1791412287989,"version":"4.3.3"},"reference-count":23,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["ard.eular.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Annals of the Rheumatic Diseases"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1136\/annrheumdis-2016-209463","type":"journal-article","created":{"date-parts":[[2016,7,19]],"date-time":"2016-07-19T02:58:33Z","timestamp":1468897113000},"page":"486-490","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis"],"prefix":"10.1016","volume":"76","clinical-trial-number":[{"clinical-trial-number":"nct00264537","registry":"10.18810\/clinical-trials-gov"}],"author":[{"given":"Joshua F","family":"Baker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G","family":"Conaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel G","family":"Baker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel","family":"Ostergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/annrheumdis-2016-209463_bib1","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1097\/RHU.0b013e3182a2164f","article-title":"Comparison of physician and patient global assessments over time in patients with rheumatoid arthritis: a retrospective analysis from the RADIUS cohort","volume":"19","author":"Markenson","year":"2013","journal-title":"J Clin Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209463_bib2","doi-asserted-by":"crossref","first-page":"2814","DOI":"10.1002\/art.34543","article-title":"Discrepancies between patients and physicians in their perceptions of rheumatoid arthritis disease activity","volume":"64","author":"Studenic","year":"2012","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1093\/rheumatology\/ket477","article-title":"Management of rheumatoid arthritis","volume":"53","author":"Baker","year":"2014","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209463_bib4","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1136\/ard.2010.149377","article-title":"Bone marrow oedema predicts structural progression in a 1-year follow-up of 85 patients with RA in remission or with low disease activity with low-field MRI","volume":"70","author":"Gandjbakhch","year":"2011","journal-title":"Ann Rheum Dis"},{"issue":"7","key":"10.1136\/annrheumdis-2016-209463_bib5","first-page":"vii36","article-title":"Imaging tools in rheumatoid arthritis: ultrasound vs magnetic resonance imaging","volume":"51","author":"Tan","year":"2012","journal-title":"Rheumatology (Oxford)"},{"key":"10.1136\/annrheumdis-2016-209463_bib6","doi-asserted-by":"crossref","first-page":"3860","DOI":"10.1002\/art.21493","article-title":"Reliability and sensitivity to change of the OMERACT rheumatoid arthritis magnetic resonance imaging score in a multireader, longitudinal setting","volume":"52","author":"Haavardsholm","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib7","doi-asserted-by":"crossref","first-page":"1968","DOI":"10.1136\/annrheumdis-2013-203444","article-title":"Early MRI measures independently predict 1-year and 2-year radiographic progression in rheumatoid arthritis: secondary analysis from a large clinical trial","volume":"73","author":"Baker","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib8","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/annrheumdis-2014-206934","article-title":"Validity of early MRI structural damage end points and potential impact on clinical trial design in rheumatoid arthritis","volume":"75","author":"Baker","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib9","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1136\/ard.2007.081331","article-title":"Level of radiographic damage and radiographic progression are determinants of physical function: a longitudinal analysis of the TEMPO trial","volume":"67","author":"van der Heijde","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib10","first-page":"501","article-title":"Minimal clinically important difference in radiological progression of joint damage. A definition based on patient perspective","volume":"33","author":"Welsing","year":"2006","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209463_bib11","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1136\/ard.2003.011544","article-title":"MRI of the wrist in early rheumatoid arthritis can be used to predict functional outcome at 6 years","volume":"63","author":"Benton","year":"2004","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib12","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1136\/ard.2008.099010","article-title":"Golimumab, a human antibody to tumour necrosis factor {alpha} given by monthly subcutaneous injections, in active rheumatoid arthritis despite methotrexate therapy: the GO-FORWARD study","volume":"68","author":"Keystone","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib13","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1136\/ard.2009.116319","article-title":"Golimumab in patients with active rheumatoid arthritis despite methotrexate therapy: 52-week results of the GO-FORWARD study","volume":"69","author":"Keystone","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib14","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1002\/art.24638","volume":"60","author":"Emery","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib15","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1002\/art.38304","article-title":"Development and validation of modified disease activity scores in rheumatoid arthritis: superior correlation with MRI synovitis and X-ray progression","volume":"66","author":"Baker","year":"2014","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib16","first-page":"1385","article-title":"OMERACT rheumatoid arthritis magnetic resonance imaging studies. Core set of MRI acquisitions, joint pathology definitions, and the OMERACT RA-MRI scoring system","volume":"30","author":"Ostergaard","year":"2003","journal-title":"J Rheumatol"},{"key":"10.1136\/annrheumdis-2016-209463_bib17","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1136\/annrheumdis-2014-205544","article-title":"Greater body mass independently predicts less radiographic progression on X-ray and MRI over 1\u20132 years","volume":"73","author":"Baker","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib18","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/art.30263","article-title":"The effects of golimumab on radiographic progression in rheumatoid arthritis: results of randomized controlled studies of golimumab before methotrexate therapy and golimumab after methotrexate therapy","volume":"63","author":"Emery","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/art.27348","article-title":"Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study","volume":"62","author":"Kremer","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib20","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/art.27268","article-title":"Two-year clinical and radiographic results with combination etanercept-methotrexate therapy versus monotherapy in early rheumatoid arthritis: a two-year, double-blind, randomized study","volume":"62","author":"Emery","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib21","doi-asserted-by":"crossref","first-page":"3702","DOI":"10.1002\/art.30634","article-title":"Joint damage in rheumatoid arthritis progresses in remission according to the Disease Activity Score in 28 joints and is driven by residual swollen joints","volume":"63","author":"Aletaha","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1136\/annrheumdis-2016-209463_bib22","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1136\/annrheumdis-2014-205302","article-title":"Comprehensive disease control (CDC): what does achieving CDC mean for patients with rheumatoid arthritis?","volume":"74","author":"Emery","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"10.1136\/annrheumdis-2016-209463_bib23","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1136\/ard.2011.154500","article-title":"Exploratory analyses of the association of MRI with clinical, laboratory and radiographic findings in patients with rheumatoid arthritis","volume":"70","author":"Emery","year":"2011","journal-title":"Ann Rheum Dis"}],"container-title":["Annals of the Rheumatic Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724028334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003496724028334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/annrheumdis-2016-209463","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,21]],"date-time":"2025-01-21T05:23:21Z","timestamp":1737437001000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003496724028334"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,3]]},"references-count":23,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S0003496724028334"],"URL":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-209463","relation":{},"ISSN":["0003-4967"],"issn-type":[{"value":"0003-4967","type":"print"}],"subject":[],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relationship of patient-reported outcomes with MRI measures in rheumatoid arthritis","name":"articletitle","label":"Article Title"},{"value":"Annals of the Rheumatic Diseases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/annrheumdis-2016-209463","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Published by Elsevier Inc. For permission to use (where not already granted under a licence) please go to http:\/\/www.bmj.com\/company\/products-services\/rights-and-licensing. Published by Elsevier B.V. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}